Dr. Jere is working as a Senior Principal Scientist, Principal group leader with Lonza Drug Product Services since 2016.
Prior to joining Lonza, he has worked with Roche in Switzerland and US for 7 years.
Dr. Jere has over 10 years of parenteral drug product development experience in early and late stage, mainly Biologics.
He has supported no. of IND/IMPDs/BAL filings for NBEs. He has also been involved in the development of novel drug delivery systems, Cell and Gene Therapy Products (ATMPs).
Dr. Jere has special expertise in CMC and regulatory requirements for intraocular drug product development and has to his credit over 30 international peered review publications and patents.
Talk will focus on integrated development approach of high concentration Drug-Device Combination Products. Importance of formulation and stability, container-closure system and application in product development. Special consideration for intravitreal injection including particulate requirements, syringeability and handling consideration for dosing.View Details